WallStreetZenWallStreetZen

NASDAQ: ONCY
Oncolytics Biotech Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ONCY earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$20.9M
Current Profit Margin
0%

ONCY Return on Equity

Current Company
-106.2%
Current Industry
-63.5%
Current Market
188%
ONCY's Return on Equity (-106.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ONCY announces earnings.

ONCY Return on Assets

Current Company
-72.9%
Current Industry
2.9%
ONCY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ONCY Return on Capital Employed

Current Company
-79.97%
Current Industry
19.5%
ONCY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ONCY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ONCY$0.00-$20.04M-$20.41MN/AN/A
LVTX$7.36M-$47.16M-$45.62M+86.44%N/A
ANEB$0.00-$10.46M-$10.49MN/AN/A
QTTB$1.16M-$110.32M-$112.96M-26.32%N/A
LPTX$0.00-$81.40M-$81.41M-100.00%N/A
View Top Biotech Stocks

ONCY earnings dates

Next earnings date
May 3, 2024

Oncolytics Biotech Earnings & Revenue FAQ

What were ONCY's earnings last quarter?

On Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q4 2023 earnings per share (EPS) of -$0.04, up 65.14% year over year. Total Oncolytics Biotech earnings for the quarter were -$2.97 million. In the same quarter last year, Oncolytics Biotech's earnings per share (EPS) was -$0.11.

If you're new to stock investing, here's how to buy Oncolytics Biotech stock.

What was ONCY's earnings growth in the past year?

As of Q2 2024, Oncolytics Biotech's earnings has grown year over year. Oncolytics Biotech's earnings in the past year totalled -$20.41 million.

What is ONCY's earnings date?

Oncolytics Biotech's earnings date is Invalid Date. Add ONCY to your watchlist to be reminded of ONCY's next earnings announcement.

What was ONCY's revenue last quarter?

On Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Oncolytics Biotech's revenue was $0.00.

What was ONCY's revenue growth in the past year?

As of Q2 2024, Oncolytics Biotech's revenue has grown null year over year. Oncolytics Biotech's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.